INVISTA has authorized Megafarma, an Azelis company, to distribute its DYTEK® Specialty Amine portfolio in Mexico. This includes DYTEK® Amine, DYTEK® DCH-99, DYTEK® HMI, and DYTEK® BHMT products.
With this new mandate, Megafarma’s CASE Division, will service customers across Mexico, with the INVISTA DYTEK® Specialty Amine portfolio.
Highlights of the Partnership
- This new mandate continues to build on Azelis’ strategic acquisition of Megafarma to expand into the Latin American CASE market.
- It aligns with Azelis’ corporate strategy of organic growth and solidifies the growth of Azelis Americas and Megafarma through the expansion of relationships of Key Principals into Mexico.
- The mandate leverages existing Azelis Americas CASE assets, including application labs, digital platforms, technical and market intelligence, in the Mexican market.
INVISTA DYTEK® Specialty Intermediates provide the amines used in curing agents for composites and laminates. The DYTEK portfolio consists of multifunctional amines developed to enable R&D chemists, formulators and manufacturers to introduce new and differentiated products, discover new routes in organic synthesis, and advance new chemistry.
Martin Hernandez Gutiérrez, director general at Megafarma, an Azelis company, comments, “
Now that we are part of the Azelis family, this agreement is an example of our commitment to expand into the CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”
“
INVISTA is excited to move forward with Megafarma representing our DYTEK® Specialty Amines. Megafarma will support our existing and new customers in Mexico via local inventory, technical assistance, and local sales representatives in every region of Mexico,” says Kris Mitchell, DYTEK® specialties global business director.
All Products from INVISTA
Source: Azelis